
Arndt Vogel/X
Apr 8, 2025, 03:42
Arndt Vogel: Clear guidance to define and improvequality standards for MTBs
Arndt Vogel, Director of the Center for Personalized Medicine at Hannover Medical School, shared a post on X:
“ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice. Clear guidance to define and improvequality standards for MTBs.”
Authors: C.B. Westphalen, L. Boscolo Bielo, P. Aftimos, H. Beltran, M. Benary, D. Chakravarty, M. Collienne, R. Dienstmann, A. El Helali, J. Gainor, P. Horak, C. Le Tourneau, C. Marchiò, C. Massard, F. Meric-Bernstam, C. Pauli, G. Pruneri, F. Roitberg, H.E.G. Russnes, D.B. Solit, N. Starling, V. Subbiah, D. Tamborero, N. Tarazona, C. Turnbull, J. van de Haar, F. André, J. Mateo, G. Curigliano
A. El Helali
Arndt Vogel
C. Le Tourneau
C. Marchió
C. Massard
C. Pauli
C. Turnbull
C.B. Westphalen
cancer
D. Chakravarty
D. Tamborero
D.B. Solit
F. André
F. Meric-Bernstam
F. Roitberg
G Curigliano
G. Pruneri
H. Beltran
H.E.G. Russnes
J. Gainor
J. Mateo
J. van de Haar
L. Boscolo Bielo
M. Benary
M. Collienne
N. Starling
N. Tarazona
OncoDaily
Oncology
P. Aftimos
P. Horak
R. Dienstmann
V Subbiah
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 18:57
Apr 15, 2025, 18:26
Apr 15, 2025, 17:49
Apr 15, 2025, 17:41